Evidence map›Paper›PMID 25378497›Full record

ArticleJournal of virology2015

Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer.

David F Boyd, Dylan Peterson, Beth S Haggarty, Andrea P O Jordan, Michael J Hogan, Leslie Goo, James A Hoxie, Julie Overbaugh

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

David F BoydDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA Pathobiology Graduate Program, University of Washington, Seattle, Washington, USA.
Dylan PetersonDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Beth S HaggartyDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Andrea P O JordanDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Michael J HoganDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Leslie GooDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA Pathobiology Graduate Program, University of Washington, Seattle, Washington, USA.
James A HoxieDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Julie OverbaughDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA joverbau@fhcrc.org.
Fred Hutch Cancer Center · USUniversity of Pennsylvania · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMENR01AI103981 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OVERBAUGH, JULIE M. · 2012 to 2015
$2.8M
Viral Pathogenesis Training ProgramT32AI083203 · NIAID · UNIVERSITY OF WASHINGTON · PI BLOOM, JESSE D, LAGUNOFF, MICHAEL · 2009 to 2023
$2.7M
EVALUATION OF CD4 INDEPENDENT HIV AND SIV ENV PROTEINSR01AI045378 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HOXIE, JAMES A · 1999 to 2003
$1.8M
NIAID NIH HHS P30 AI045008NIAID NIH HHS R01 AI045378NIAID NIH HHS R01 AI103981NIAID NIH HHS T32 AI083203NIAID NIH HHS T32AI083203NIH HHS P51 OD011104
6 · The paper itself

Abstract

unlabelledChimeric simian immunodeficiency virus (SIV)/human immunodeficiency virus (HIV) (SHIV) infection of macaques is commonly used to model HIV type 1 (HIV-1) transmission and pathogenesis in humans. Despite the fact that SHIVs encode SIV antagonists of the known macaque host restriction factors, these viruses require additional adaptation for replication in macaques to establish a persistent infection. Additional adaptation may be required in part because macaque CD4 (mCD4) is a suboptimal receptor for most HIV-1 envelope glycoprotein (Env) variants. This requirement raises the possibility that adaptation of HIV-1 Env to the macaque host leads to selection of variants that lack important biological and antigenic properties of the viruses responsible for the HIV-1 pandemic in humans. Here, we investigated whether this adaptation process leads to changes in the antigenicity and structure of HIV-1 Env. For this purpose, we examined how two independent mutations that enhance mCD4-mediated entry, A204E and G312V, impact antibody recognition in the context of seven different parental HIV-1 Env proteins from diverse subtypes. We also examined HIV-1 Env variants from three SHIVs that had been adapted for increased replication in macaques. Our results indicate that these different macaque-adapted variants had features in common, including resistance to antibodies directed to quaternary epitopes and sensitivity to antibodies directed to epitopes in the variable domains (V2 and V3) that are buried in the parental, unadapted Env proteins. Collectively, these findings suggest that adaptation to mCD4 results in conformational changes that expose epitopes in the variable domains and disrupt quaternary epitopes in the native Env trimer. IMPORTANCE: These findings indicate the antigenic consequences of adapting HIV-1 Env to mCD4. They also suggest that to best mimic HIV-1 infection in humans when using the SHIV/macaque model, HIV-1 Env proteins should be identified that use mCD4 as a functional receptor and preserve quaternary epitopes characteristic of HIV-1 Env.

Indexed as

Mutation, MissenseVirus InternalizationAdaptation, BiologicalAnimalsCD4 AntigensCD4-Positive T-Lymphocytesenv Gene Products, Human Immunodeficiency VirusEpitopesHIV-1HIV AntibodiesHumansMacacaModels, MolecularMutant ProteinsProtein ConformationCD4 Antigensenv Gene Products, Human Immunodeficiency VirusEpitopesHIV AntibodiesMutant Proteins

Identifiers

PMID25378497
PMCPMC4300673
OpenAlexW2072847081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.